Early biological therapy within the first 12 months after diagnosis leads to higher clinical, endoscopic, and transmural remission in Crohn’s disease: European multicentre study with a propensity-score matched analysis

J. Revés; A. Fernandez-Clotet; I. Ordás; A. Buisson; P. Ellul; A. Elorza; M. Aduna; I. Rodríguez-Lago; G. Freire; P. Sousa; A. Primitivo; I. Delgado; I. Sousa Lajas; A. Raimundo; P. Bettencourt; J. Rimola; J. Torres

doi:10.1093/ecco-jcc/jjac190.0711

Early biological therapy within the first 12 months after diagnosis leads to higher clinical, endoscopic, and transmural remission in Crohn’s disease: European multicentre study with a propensity-score matched analysis

J. Revés, A. Fernandez-Clotet, I. Ordás, A. Buisson, P. Ellul, A. Elorza, M. Aduna, I. Rodríguez-Lago, G. Freire, P. Sousa, A. Primitivo, I. Delgado, I. Sousa Lajas, A. Raimundo, P. Bettencourt, J. Rimola, J. Torres

Research output: Contribution to journal › Meeting Abstract › peer-review

1 Downloads

Original language	English
Article number	P581
Journal	Journal of Crohn's and Colitis
Volume	17
Issue number	S1
DOIs	https://doi.org/10.1093/ecco-jcc/jjac190.0711
Publication status	Published - 30 Jan 2023

Access to Document

10.1093/ecco-jcc/jjac190.0711Licence: Other

Cite this

Revés, J., Fernandez-Clotet, A., Ordás, I., Buisson, A., Ellul, P., Elorza, A., Aduna, M., Rodríguez-Lago, I., Freire, G., Sousa, P., Primitivo, A., Delgado, I., Lajas, I. S., Raimundo, A., Bettencourt, P., Rimola, J., & Torres, J. (2023). Early biological therapy within the first 12 months after diagnosis leads to higher clinical, endoscopic, and transmural remission in Crohn’s disease: European multicentre study with a propensity-score matched analysis. Journal of Crohn's and Colitis, 17(S1), Article P581. https://doi.org/10.1093/ecco-jcc/jjac190.0711

@article{b0da136136f949238edcb2a88148d2b1,

title = "Early biological therapy within the first 12 months after diagnosis leads to higher clinical, endoscopic, and transmural remission in Crohn{\textquoteright}s disease: European multicentre study with a propensity-score matched analysis",

author = "J. Rev{\'e}s and A. Fernandez-Clotet and I. Ord{\'a}s and A. Buisson and P. Ellul and A. Elorza and M. Aduna and I. Rodr{\'i}guez-Lago and G. Freire and P. Sousa and A. Primitivo and I. Delgado and Lajas, \{I. Sousa\} and A. Raimundo and P. Bettencourt and J. Rimola and J. Torres",

year = "2023",

month = jan,

day = "30",

doi = "10.1093/ecco-jcc/jjac190.0711",

language = "English",

volume = "17",

journal = "Journal of Crohn's and Colitis",

issn = "1873-9946",

publisher = "Oxford University Press",

number = "S1",

}

Revés, J, Fernandez-Clotet, A, Ordás, I, Buisson, A, Ellul, P, Elorza, A, Aduna, M, Rodríguez-Lago, I, Freire, G, Sousa, P, Primitivo, A, Delgado, I, Lajas, IS, Raimundo, A, Bettencourt, P, Rimola, J & Torres, J 2023, 'Early biological therapy within the first 12 months after diagnosis leads to higher clinical, endoscopic, and transmural remission in Crohn’s disease: European multicentre study with a propensity-score matched analysis', Journal of Crohn's and Colitis, vol. 17, no. S1, P581. https://doi.org/10.1093/ecco-jcc/jjac190.0711

Early biological therapy within the first 12 months after diagnosis leads to higher clinical, endoscopic, and transmural remission in Crohn’s disease: European multicentre study with a propensity-score matched analysis. / Revés, J.; Fernandez-Clotet, A.; Ordás, I. et al.
In: Journal of Crohn's and Colitis, Vol. 17, No. S1, P581, 30.01.2023.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - Early biological therapy within the first 12 months after diagnosis leads to higher clinical, endoscopic, and transmural remission in Crohn’s disease

T2 - European multicentre study with a propensity-score matched analysis

AU - Revés, J.

AU - Fernandez-Clotet, A.

AU - Ordás, I.

AU - Buisson, A.

AU - Ellul, P.

AU - Elorza, A.

AU - Aduna, M.

AU - Rodríguez-Lago, I.

AU - Freire, G.

AU - Sousa, P.

AU - Primitivo, A.

AU - Delgado, I.

AU - Lajas, I. Sousa

AU - Raimundo, A.

AU - Bettencourt, P.

AU - Rimola, J.

AU - Torres, J.

PY - 2023/1/30

Y1 - 2023/1/30

U2 - 10.1093/ecco-jcc/jjac190.0711

DO - 10.1093/ecco-jcc/jjac190.0711

M3 - Meeting Abstract

SN - 1873-9946

VL - 17

JO - Journal of Crohn's and Colitis

JF - Journal of Crohn's and Colitis

IS - S1

M1 - P581

ER -

Revés J, Fernandez-Clotet A, Ordás I, Buisson A, Ellul P, Elorza A et al. Early biological therapy within the first 12 months after diagnosis leads to higher clinical, endoscopic, and transmural remission in Crohn’s disease: European multicentre study with a propensity-score matched analysis. Journal of Crohn's and Colitis. 2023 Jan 30;17(S1):P581. doi: 10.1093/ecco-jcc/jjac190.0711